Therapeutic potential of ivermectin as add on treatment in COVID 19: A systematic review and meta-analysis
The current management of COVID-19 is mostly limited to general supportive care and symptomatic treatment. Ivermectin is a broad-spectrum anti-parasitic drug used widely for the treatment of onchocerciasis and lymphatic filariasis. Apart from its anti-parasitic effect it also exhibits antiviral acti...
Main Authors: | Biswa Mohan Padhy, Rashmi Ranjan Mohanty, Smita Das, Bikash Ranjan Meher |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Journal of Pharmacy & Pharmaceutical Sciences |
Online Access: | https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/31457 |
Similar Items
-
Effectiveness of pulse dose methyl prednisolone in management of COVID 19: A systematic review and meta-analysis of observational studies.
by: Rashmi Ranjan Mohanty, et al.
Published: (2022-03-01) -
Efficacy and safety of abrocitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials
by: Bikash Ranjan Meher, et al.
Published: (2022-05-01) -
Seeding trials: Marketing gimmick or credible scientific research
by: Biswa Mohan Padhy, et al.
Published: (2019-01-01) -
Stroke in young with hyperhomocysteinemia: A case report
by: Rashmi Ranjan Mohanty, et al.
Published: (2017-01-01) -
Effect of Ivermectin prophylaxis in prevention of COVID 19: Meta-analysis and systematic review
by: Manisha Kujur, et al.
Published: (2022-01-01)